Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

The 3 Top Dividend-Paying Defense Stocks to Buy for 2024

Geopolitical tensions are mounting. It's a great time to secure your portfolio with these three dividend-paying defense stocks.

Exit Now! 3 Penny Stocks to Sell in February 2024

These penny stocks to sell are in bad shape now, and the situation is likely to go from bad to worse in the future.

3 Lithium Stocks That Could Be Multibaggers in the Making: February Edition

The lithium industry had a terrible 2023. The current bust has created compelling opportunities in these three lithium stocks.

It’s Time! 3 High-Risk Nasdaq Stocks to Sell in February.

Markets are soaring as fields such as semiconductors and AI take off. However, these three risky Nasdaq stocks to sell are too hot to handle.

3 Poorly Performing IPOs Worth Snatching Up Before They Surge

A lot of recent IPOs have sold off sharply since their debuts. These three discounted IPOs are set to come roaring back.

Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024

U.S. indices are hitting new all-time highs seemingly every week. Traders are enthusiastic, but some analysts are warning of a potential market bubble. In fact,…

3 Hydrogen Stocks That Could Be Multibaggers in the Making: February Edition

Hydrogen is an emerging green power source with plenty of volatility. These three hydrogen stocks can deliver steady profits going forward.

The 3 Best Nasdaq Stocks to Buy in February 2024

These three Nasdaq stocks to buy now offer solid growth prospects, favorable starting valuations, and some dividend income in one package.

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.

Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

The 7 Best Dividend Stocks to Buy in February 2024

The market is soaring and many sectors appear overvalued. Fortunately, these leading dividend stocks are still available at great prices.